KBRA Assigns Ratings to PFP 2023-10
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA is pleased to announce the assignment of ratings to eight classes of…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA is pleased to announce the assignment of ratings to eight classes of…
Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Person Commercial Team to Enhance Market…
Real-world evidence demonstrates the clinical, health equity and patient benefits of AI-powered care coordination. SAN…
MOBILE, Ala.–(BUSINESS WIRE)–CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that Mark V. Anquillare…
The second major release of Alight Worklife for 2023 builds on the platform’s AI foundation,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
TORONTO, July 31, 2023 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX…
TORONTO, July 31, 2023 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX…
ROCKVILLE, MD, July 31, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
ROCKVILLE, MD, July 31, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage…
REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage…
Stable disease was observed in three out of seven heavily pretreated patients No dose-limiting toxicities…
Stable disease was observed in three out of seven heavily pretreated patients No dose-limiting toxicities…
Designation indicates entry into the U.K.’s Innovative Licensing and Access Pathway (ILAP) NEW HAVEN, Conn. and…
Cidara’s U.S. Commercial Partner, Melinta Therapeutics, has Initiated Commercial Launch of REZZAYO™ EMA Regulatory Decision…
WOODBRIDGE, Va.–(BUSINESS WIRE)–The NRP Group – a vertically integrated, best-in-class developer, builder, and manager of…
IRVINE, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company”…
Montrouge, France, July 31, 2023 DBV Technologies Receives Feedback from FDA on Design Elements for…
Cybersecurity Threat Report dissects 23.5 billion attempted cybersecurity attacks against Comcast Business customers – phishing…